# Transgene Biotek Ltd (TRABI)
> Exchange: NSE | Sector: Pharma | ISIN: INE773D01018

## Price
Current Price: ₹3.2
Day Change: +2.89%
52W High: ₹5.26
52W Low: ₹1.83
Market Cap: ₹24 Cr

## Valuation
P/E: 0
P/B: 2.7
EPS: ₹-0.25
Book Value: ₹1.18
Dividend Yield: 0%

## Returns
1Y Return: -16.45%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Transgene Biotek Ltd is a Biotechnology company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Biotechnology
Sub Industry: Unknown

## Business Model
Overview: Transgene Biotek Ltd makes money through Technology services, Digital transformation projects, Maintenance and managed services in Biotechnology. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Technology services
- Digital transformation projects
- Maintenance and managed services
Operating Model:
- Wins client contracts, deploys skilled delivery teams, and earns project or recurring service revenue.
- Utilisation, billing rates, attrition, and currency movements are key operating levers.
Recent Context:
- Announcement: Board Meeting Intimation for Intimation Of The Board Meeting Of The Company - This Is To Inform You That A Meeting Of Board Of Directors Of The Company Will Be Held On Friday 29Th May 2026.
- Announcement: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
- BSE Filing: Board Meeting Intimation for Intimation Of The Board Meeting Of The Company - This Is To Inform You That A Meeting Of Board Of Directors Of The Company Will Be Held On Friday 29Th May 2026.

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-18T07:00:19.418Z
Price History Updated: 2026-05-25T05:26:35.399Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-25T05:26:35.399Z
Quant Updated: 2026-05-25T05:26:35.399Z
Sentiment Updated: 2026-05-25T05:26:35.399Z
Financials Status: stale
Financials Updated: 2026-05-18T15:30:00.976Z
Financials Last Attempt: 2026-05-18T15:30:00.976Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2015)
Revenue: ₹0.98 Cr
Operating Profit: ₹-1.83 Cr (OPM -186.73%)
Net Profit: ₹-133.41 Cr
Tax: ₹-133.42 Cr

## Annual P&L History
Mar 2015: Rev ₹0.98Cr | PAT ₹-133.41Cr | OPM -186.73%
Mar 2016: Rev ₹0.3Cr | PAT ₹-19.14Cr | OPM -533.33%
Mar 2017: Rev ₹0.18Cr | PAT ₹-21.54Cr | OPM -633.33%

## Balance Sheet (Mar 2015)
Total Assets: ₹358.35 Cr
Total Liabilities: ₹358.35 Cr
Borrowings: ₹13.06 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/trabi
Disclaimer: For research and education only. Not investment advice.